Loading…

Medical record convergence for hla reporting across the enterprise

Aim One of Mayo Clinic’s missions is to standardize care through an integrated clinical practice. Reporting histocompatibility results is very complex and HLA labs have different ways of interpreting results. By standardizing across the three sites we improve the interchangeability of test results,...

Full description

Saved in:
Bibliographic Details
Published in:Human immunology 2015-10, Vol.76, p.48-48
Main Authors: Hallaway, Lisa, Wakefield, Laurie, Kreuter, Justin, Rowans, Lauren, Kahle, David, Elrefaei, Mohamed, Genco, Petrina, Desmarteau, Yvonne, Stoll, Scott, Pando, Marcelo J, Valdez, Riccardo, La, Hieu, Mattey, Michelle, Feehan, Barb, Kloeppel, Brooke, Townshend, Scot, Gandhi, Manish
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim One of Mayo Clinic’s missions is to standardize care through an integrated clinical practice. Reporting histocompatibility results is very complex and HLA labs have different ways of interpreting results. By standardizing across the three sites we improve the interchangeability of test results, reduce resources to support our practice, provide the best standard of care for our patients and support for our physicians for the Mayo paired kidney exchange program. Methods Integration was defined as: Each lab will use HistoTrac as the lab management system. HistoTrac will interface with the lab integrated system (LIS) for processing of orders and reporting results to the medical record. Each lab will report the same discreet result values and interpretive reports. Each lab will use the same vendor and lot number if possible for antibody and typing tests. A project group was created which includes: a director and technical specialist from each site, a business analyst, and a computer programmer. This team worked together using conference calls and web meetings to establish standardization for reporting HLA typing, antibody and crossmatch results. Results The results reported at each site will use the same test definitions, reporting templates, and will be transferred to the LIS. We encountered some obstacles due to: lab practice differences, transplant policies and business requirements. The convergence effort is still ongoing at each site: MN: update reporting and implement interpretive reports AZ: implement an interface to the LIS and update interpretive reports FL: implement HistoTrac with an interface to the LIS and update interpretive reports Conclusion All histocompatibility data and interpretive reports will be available in the medical record at each mayo site. Convergence of reporting test results will improve the communication and understanding when evaluating a patient while making the process cost effective. The next step in convergence is reporting to one medical record at all three sites.
ISSN:0198-8859
1879-1166
DOI:10.1016/j.humimm.2015.07.067